Simultaneous quantification of activated immune cells and PD-L1 expressing circulating tumor cells (CTCs) in peripheral blood of cancer patients receiving checkpoint inhibitor therapy

被引：0
|
作者：
Krupa, Rachel [1 ]
Richardson, Robin [1 ]
Ontiveros, Priscilla [1 ]
Schonhoft, Joseph [1 ]
Byun, Jiyun [1 ]
Lu, David [1 ]
Nisperos, Sean [1 ]
Wang, Yipeng [1 ]
Landers, Mark [1 ]
Dittamore, Ryan [1 ]
机构：
[1] Epic Sci, San Diego, CA USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-4039
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4039
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Quantification of activated and exhausted immune cell populations and simultaneous characterization of circulating tumor cells (CTCs) in peripheral blood of cancer patients receiving checkpoint inhibitor therapy.
    Vansant, Gordon
    Krupa, Rachel
    Richardson, Robin
    Ontiveros, Priscilla
    Byun, Jiyun
    Landers, Mark
    Dittamore, Ryan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] PD-L1 expressing circulating tumor cells (CTCs) in patients with breast cancer
    Zavridou, Martha
    Strati, Areti
    Malamos, Nikos
    Georgoulias, Vasilis
    Lianidou, Evi S.
    [J]. CANCER RESEARCH, 2016, 76
  • [3] Simultaneous characterization and quantification of immune cell subpopulations and PD-L1 expressing CTCs in peripheral blood of cancer patients
    Krupa, Rachel
    Lu, David
    Jendrisak, Adam
    Rodriguez, Angel
    Ebrahim, Nadia
    Richardson, Robin
    Nisperos, Sean
    Graf, Ryon
    Byun, Jiyun
    Wang, Yipeng
    Landers, Mark
    Dittamore, Ryan
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [4] Quantification of rare PD-L1 expressing leukocytes and CTCs in peripheral blood of cancer patients
    Jendrisak, Adam
    Byun, Jiyun
    Suraneni, Mahipal
    Lu, David
    Krupa, Rachel
    Orr, Sarah
    Graf, Ryon
    Wang, Yipeng
    Landers, Mark
    Dittamore, Ryan
    [J]. CANCER RESEARCH, 2017, 77
  • [5] Assessment of PD-L1 expression on circulating tumor cells (CTCs) and immune cells in peripheral blood of patients with small cell lung cancer (SCLC)
    Papadaki, M. A.
    Kapetanaki, E-E.
    Vorrias, E.
    Mavroudis, D.
    Agelaki, S.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1166 - S1166
  • [6] PD-L1 profiling of circulating tumor cells for immune checkpoint inhibitor therapy in gastroesophageal cancers
    Devhare, Pradip
    Patil, Revati
    Akolkar, Dadasaheb B.
    Patil, Darshana
    Srivastava, Navin
    Fulmali, Pooja
    Patel, Shoeb
    Shejwalkar, Pradyumna
    Datta, Vineet
    Sims, Cynthe
    Srinivasan, Ajay
    Datar, Rajan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [7] Simultaneous characterization of rare immune cell subpopulations and PD-L1 expressing CTCs in peripheral blood of cancer patients
    Jendrisak, Adam
    Rodriguez, Angel
    Byun, Jiyun
    Graf, Ryon
    Wang, Yipeng
    Landers, Mark
    Dittamore, Ryan
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [8] PD-L1 profiling of circulating tumor cells for immune checkpoint inhibitor therapy in head and neck cancers
    Patil, Revati
    Akolkar, Dadasaheb B.
    Patil, Darshana
    Devhare, Pradip
    Srivastava, Navin
    Fulmali, Pooja
    Patel, Shoeb
    Shejwalkar, Pradyumna
    Datta, Vineet
    Sims, Cynthe
    Srinivasan, Ajay
    Datar, Rajan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [9] PD-L1 expressing circulating tumor cells (CTCs) in patients with head and neck squamous cell carcinoma (HNSCC)
    Strati, Areti
    Koutsodontis, George
    Angelidis, Was
    Sasaki, Clarence
    Avgeris, Margaritis
    Psyrri, Amanda
    Lianidou, Evi S.
    [J]. CANCER RESEARCH, 2016, 76
  • [10] The expression and analysis of PD-L1 in peripheral blood circulating tumor cells of lung cancer
    Wang, Wei
    Zhang, Tao
    [J]. FUTURE ONCOLOGY, 2021, 17 (13) : 1625 - 1635
12345